Parity for Non-Opioid Pain Management Drugs

Summary

The bill adds rules that prescription‑drug carriers cannot place stricter prior‑authorization or cost‑sharing requirements on FDA‑approved non‑opioid pain medicines than they do on opioids. Starting in 2027 for individual and small‑group plans, and 2028 for large‑employer plans, insurers must also include at least one clinically appropriate non‑opioid alternative to any opioid drug. The measure aims to expand access to non‑opioid pain treatments while limiting additional costs to patients.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share